All services

Smits 2007 CHIP rule (adults ≥16, GCS 13-15). CT if ≥1 major (pedestrian/cyclist vs vehicle, ejected, vomiting, PTA ≥4 h, skull-fracture signs, GCS <15, GCS drop ≥2 at 1 h, anticoagulants, posttraumatic seizure, age ≥60) or ≥2 minor (fall from elevation, persistent anterograde amnesia, PTA 2 to <4 h, skull contusion, neurologic deficit, LOC, GCS drop of 1 at 1 h, age 40-60). Not a diagnosis; not Canadian CT Head, NEXUS, PECARN, or 2022 CHIP. magent does not examine the patient.

Kessler 2005 Adult ADHD Self-Report Scale (ASRS) v1.1 Part A: six caller-assigned 0-4 items (never to very often). wrap_up, organization, and remembering count at sometimes or more; avoid_delay, fidget, and motor count at often or more. Screen-positive at ≥4 of 6. Not an ADHD diagnosis, not a medical device, and not the 18-item ASRS or later 0-24 sum cutoffs. magent does not interpret the items.

Mearin 2016 Rome IV C4 bloating/distension. rome_iv_bloating is true iff last-3-months criteria with 6-month onset, recurrent bloating or distension ≥1 day/week that predominates, and insufficient criteria for IBS, functional constipation, functional diarrhea, or PDS. Caller assigns three flags. magent does not examine the patient. Not a diagnosis. Adult C4 only. Not child, not IBS, not functional constipation, not functional diarrhea, not PDS or functional dyspepsia.

Revised Tokuhashi 2005 (0-15). KPS poor/moderate/good 0/1/2. Extraspinal ge_3/one_or_two/none 0/1/2. Vertebral ge_3/two/one 0/1/2. Visceral unremovable/removable/none 0/1/2. Primary lung osteosarcoma stomach bladder esophagus pancreas 0; liver gallbladder unidentified 1; others 2; kidney uterus 3; rectum 4; thyroid prostate breast carcinoid 5. Palsy complete/incomplete/none 0/1/2. Bands 0-8/9-11/12-15. Not an operative order. Not 1990. Not SINS. Does not read imaging. Not a medical device.

Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-tier class), absence of type 1/like CALR 1, ASXL1 1, SRSF2 1, U2AF1Q157 1 (not S34); max 6. Low 0, intermediate_1 1, intermediate_2 2, high ≥3. Published median (5-year) survivals 26.4 y (94%), 8.0 y (73%), 4.2 y (40%), 2 y (14%). Not DIPSS or MIPSS70-plus. magent does not karyotype or sequence.

Waist–hip ratio from waist and hip circumference (WHO 2011 expert consultation). WHR = waist_cm / hip_cm after the same unit normalize; optional inches convert as cm = in * 2.54. Deterministic published arithmetic with citation. Not a medical device, body-fat diagnosis, or cardiovascular diagnosis; magent does not apply obesity or sex-specific cutoffs and does not measure the patient.

Turner 2007 pediatric ulcerative colitis activity index (PUCAI): six caller-assigned item points (abdominal pain, rectal bleeding, stool consistency of most stools, stools per 24 hours, nocturnal stools, activity level) using that paper's published integers. magent sums only (max 85) and returns the published activity band (<10 remission, 10-34 mild, 35-64 moderate, ≥65 severe). magent does not examine the child. Not a diagnosis and not the adult Mayo score.

Bergstrom 1987 Braden Scale: six caller-assigned subscales — sensory_perception, moisture, activity, mobility, nutrition (each 1-4) and friction_shear (1-3). magent sums only (range 6-23; lower is higher pressure-sore risk) and returns at_risk true iff score ≤16, the only cutoff in that paper's predictive-validity studies. magent does not examine the patient. Not a medical device, not a diagnosis, and not a treatment plan.

Harrison 2008 BARD score for NAFLD advanced fibrosis: BMI ≥28 kg/m² (1), AST/ALT ≥0.8 (2), diabetes mellitus (1); max 4. Low 0–1, high 2–4 (paper 2–4 vs 0–1 split). Not a NASH diagnosis; magent does not interpret a biopsy or compute BMI. Not FIB-4, APRI, or the NAFLD fibrosis score.

CLL-IPI 2016 for chronic lymphocytic leukaemia: TP53 abnormality (del(17p) and/or TP53 mutation) 4, unmutated IGHV 2, beta-2 microglobulin >3.5 mg/L 2, advanced stage (Binet B/C or Rai I–IV) 1, age >65 1; max 10. Low 0–1, intermediate 2–3, high 4–6, very_high 7–10. Deterministic published score with citation; not a CLL diagnosis; not Shipp IPI; not MIPI. magent does not assay TP53, IGHV, or beta-2 microglobulin.

Belgrade 2006 DIRE score: Diagnosis, Intractability, and Efficacy each caller-assigned 1-3; Risk is the sum of Psychological, Chemical, Reliability, and Social support (each 1-3, so Risk 4-12). Total 7-21. Scores 14-21 are more suitable for long-term opioid maintenance; 7-13 less suitable. Caller assigns the integers. magent does not take a pain history or write an opioid prescription or taper. Not a medical device.

Best 1976 Crohn's disease activity index (CDAI): eight weighted variables (7-day liquid stools *2, abdominal-pain sum *5, well-being sum *7, extra-intestinal count *20, antidiarrheal *30, abdominal mass 0/2/5 *10, hematocrit deficit *6, caller-assigned weight-percent deviation). magent returns the rounded integer index only and does not apply later trial activity bands. magent does not examine the patient. Not a Crohn's diagnosis and not the Harvey-Bradshaw one-day index.

Gélinas 2006 CPOT from four caller-assigned 0-2 items (facial_expression, body_movements, muscle_tension, plus ventilator_compliance when intubated or vocalization when extubated) using that paper's 0/1/2 descriptors. magent sums only (max 8) and does not observe the patient. No later intensity cutoffs. Not a pain diagnosis or analgesic order. Not PAINAD.

SLICC 2012 SLE classification (Petri Table 3). classified iff biopsy-proven lupus nephritis plus ANA or anti-dsDNA, or at least four criteria including at least one clinical and one immunologic. 11 clinical and 6 immunologic caller flags. Direct Coombs counts only in the absence of hemolytic anemia. Criteria need not be concurrent. Not a diagnosis. Not 1997 ACR. Not 2019 EULAR/ACR. magent does not examine skin, assay serologies, or read a biopsy.

Shorr 2013 MRSA pneumonia risk score (Table 2 only, not HCAP, not DRIP): recent hospitalization ≥2 days in 90 days 2; ICU admission 2; age <30 or >79 1; prior IV antibiotics 1; dementia 1; cerebrovascular disease 1; female with diabetes 1 (male with diabetes 0); nursing home/LTAC/SNF 1; max 10. Bands: 0-1 low, 2-5 medium, ≥6 high. Returns score, max_score, and risk_band. Not a medical device and not an antibiotic order.

VA TPN 1991 Nutritional Risk Index (NEJM): NRI = 1.519*albumin_g_l + 41.7*(current/usual weight). Malnourished if NRI <= 100. Strata: not_malnourished if NRI > 100; borderline_malnourished if 97.5 < NRI <= 100; mildly_malnourished if 83.5 <= NRI <= 97.5; severely_malnourished if NRI < 83.5. Does not cap current/usual at 1. Not a malnutrition diagnosis or TPN order. magent does not assay albumin or weigh the patient. Not GNRI or PNI.

AKIN 2007 (Mehta Table 2) stage 0-3 from baseline and current creatinine in mg/dL and a caller-assigned urine-output category. Stage is the worse of the two limbs; RRT is stage 3. magent does not assay creatinine, measure urine, or collect weight. Not a medical device, not a diagnosis, not KDIGO 2012, and not RIFLE.

du Bois 2011 abbreviated four-predictor IPF score from age (<60 → 0, 60–69 → 4, ≥70 → 8), 24-week respiratory hospitalization (true → 14), FVC % predicted (<50 → 18, 51–65 → 13, 66–79 → 8, >80 → 0; 50 and 80 unpublished), and 24-week FVC % change (≤ −10 → 21, > −10 and < −4.9 → 10, ≥ −4.9 → 0). Returns a 0–61 total only. Does not interpolate Table 4 risk percents. Not GAP and not a transplant listing.

AHA 2017 classic/complete Kawasaki disease (McCrindle). Complete when fever_days >= 4 and at least 4 of 5 principal features are true (oral mucosal changes, bilateral conjunctival injection, rash, extremity changes, cervical lymphadenopathy). Does not implement the incomplete-KD lab/echo algorithm or the 3-day clinician exception. magent does not examine the patient or read an echocardiogram. Not a medical device and not a diagnosis.

Chang 2017 three-variable rebound hyperbilirubinemia score: +15 if GA <38 weeks, −7 × age at phototherapy start in days, −4 × (caller AAP phototherapy threshold − TSB at termination), +50. Scores <20 correspond to a <4% chance of TSB returning to threshold within 72 hours. magent does not assay bilirubin or compute the AAP nomogram. Not Chang 2019. Not a phototherapy order.

Travis 1996 day-3 of intravenous steroids for severe ulcerative colitis. travis_high is true when stools_per_day > 8, or when stools_per_day is 3 to 8 inclusive and crp_mg_l > 45. Stools 8 with CRP 45 is not high. Stools 2 with high CRP is not high. Both parameters are required. Not a colectomy order, not the Ho score, and not Truelove and Witts. magent does not count stools or measure CRP.

Guilbert 2004 mAPI (PEAK Table I). Positive if 4+ wheeze episodes in one year (one MD-diagnosed) plus 1+ major or 2+ minor. Majors: parental asthma, MD atopic dermatitis, aeroallergen sensitization. Minors: milk/egg/peanut sensitization, wheezing unrelated to colds, eosinophils ≥4%. Not original API. Not m²API. Not an asthma diagnosis. magent does not examine the child. Not a medical device.

Pérez de la Ossa 2014 Rapid Arterial oCclusion Evaluation (RACE) scale: facial_palsy 0 absent / 1 mild / 2 moderate to severe + arm_motor 0 normal to mild / 1 moderate / 2 severe + leg_motor same + gaze_deviation 0 absent / 1 present + cortical 0-2 (aphasia if right hemiparesis; agnosia if left). Max 9. lvo_suggested true iff score ≥5. Not a stroke diagnosis or transfer order and not a race-based equation. magent does not examine the patient.

Duval 2010 AML Table 5 (not ALL): PIF or CR1 >6 mo 0 / CR1 <6 mo 1; ECOG/SWOG cyto good/intermediate 0, poor 1; HLA sibling or well/partially matched unrelated 0, mismatched unrelated 1, related other 2; circulating blasts 1; KPS/Lansky <90 1; max 6. Groups 0, 1, 2, ≥3. Caller assigns categories; magent does not karyotype. Not a transplant listing.